Giuseppe Rosano

Giuseppe Rosano

Consultant Cardiologist and Professor of Cardiology (Hon)

MD

St George’s University Medical School of London, UK

  • LinkedIn
  • Radcliffe
  • OrcidID

Biography

Giuseppe Rosano is Consultant Cardiologist and Professor of Cardiology at St George’s, University of London where he is also the director of MSc Heart Failure.

After obtaining his MD in Medicine and Surgery at the La Sapienza University of Rome, Prof Rosano obtained his specialisation in cardiology from the same University before attaining his PhD in Medical Sciences from Imperial College London. His research interests focus on experimental and clinical pharmacology, heart failure, cardiac metabolism, diabetes and gender differences in cardiovascular diseases.

Prof Rosano has been core member of the Cardiovascular Working Party of the European Medicines Agency and member of the Pricing and Reimbursement Committee of the Italian Drug Agency. He is the President-Elect of the Heart Failure Association Board (HFA), and Chairman of the Education Committee of the HFA. Prof Rosano is on the editorial board for European Journal of Heart Failure, European Heart Journal CV Pharmacotherapy, Cardiac Failure Reviews and Cardiovascular Diabetology. He has authored more than 500 peer-reviewed articles, eight books and 32 book chapters.

Dr Giuseppe Rosano is Deputy Editor-in-Chief of Cardiac Failure Review.

Read more

Media

Giuseppe Rosano, Mikhail Kosiborod, Biykem Bozkurt, et al

Andrew JS Coats, Giuseppe Rosano,

Shelley Zieroth, Martin R Cowie, Javed Butler, et al

Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice

Giuseppe Rosano, David Quek, Felipe Martínez, et al

Juan Carlos Kaski, Giuseppe Rosano, Alexander Lyon, et al

Juan Carlos Kaski, Giuseppe Rosano, Theresa A McDonagh, et al

ESC 2019: DAPA-HF - A perspective - Prof Giuseppe Rosano

Giuseppe Rosano,

ESC 2015: True advances in the treatment of heart failure

Giuseppe Rosano,

Articles by Giuseppe Rosano, Consultant Cardiologist and Professor of Cardiology (Hon)

Medical Treatment of Heart Failure with Reduced Ejection Fraction in the Elderly

Ivan Milinkovic, Marija Polovina, Andrew JS Coats, et al

Published:

Citation: Cardiac Failure Review 2022;8:e17.

DOI:

https://doi.org/10.15420/cfr.2021.14
Foreword

Andrew JS Coats, Giuseppe Rosano,

Published:

Citation: Cardiac Failure Review 2019;5(2):68–9.

DOI:

https://doi.org/10.15420/cfr.2019.14.1
Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction

Giuseppe Rosano, Ilaria Spoletini, Cristiana Vitale, et al

Published:

Citation: Cardiac Failure Review 2019;5(3):130–2.

DOI:

https://doi.org/10.15420/cfr.2019.8.2
Foreword

Andrew JS Coats, Giuseppe Rosano,

Published:

Citation: Cardiac Failure Review 2019;5(3):128–9.

DOI:

https://doi.org/10.15420/cfr.2019.5.3.FO1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2019;5(1):4.

DOI:

https://doi.org/10.15420/cfr.2019.4.1
Erratum to: Foreword

Andrew JS Coats, Giuseppe Rosano,

Published:

Citation: Cardiac Failure Review 2019;5(1):62.

DOI:

https://doi.org/10.15420/cfr.2018.34.1
Pharmacological Interventions Effective in Improving Exercise Capacity in Heart Failure

Cristiana Vitale, Ilaria Spoletini, Giuseppe Rosano, et al

Citation: Cardiac Failure Review 2018;4(1):25–7.

DOI:

https://doi.org/10.15420/cfr.2018:8:2
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2018;4(2):68-9.

DOI:

https://doi.org/10.15420/cfr.2018.33.1
Metabolic Modulation of Cardiac Metabolism in Heart Failure

Giuseppe Rosano, Cristiana Vitale,

Citation: Cardiac Failure Review 2018;4(2):99–103.

DOI:

https://doi.org/10.15420/cfr.2018.18.2
Frailty in Heart Failure: Implications for Management

Cristiana Vitale, Ilaria Spoletini, Giuseppe Rosano, et al

Citation: Cardiac Failure Review 2018;4(2):104–6.

DOI:

https://doi.org/10.15420/cfr.2018.22.2
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2018;4(1):4–5

DOI:

https://doi.org/10.15420/cfr.2018.4.1.FO1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2017;3(2):77–8.

DOI:

https://doi.org/10.15420/cfr.2017:3:2:77
Heart Failure in Patients with Diabetes Mellitus

Giuseppe Rosano, Cristiana Vitale, Petar M Seferovic, et al

Citation: Cardiac Failure Review 2017;3(1):52–5.

DOI:

https://doi.org/10.15420/cfr.2016:20:2
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2017;3(1):5–6

DOI:

https://doi.org/10.15420/cfr.2017:3:1:5
Practical Applications for Single Pill Combinations in the Cardiovascular Continuum

Ferdinando Iellamo, Karl Werdan, Krzysztof Narkiewicz, et al

Citation: Cardiac Failure Review 2017;3(1):40–5.

DOI:

https://doi.org/10.15420/cfr.2017:5:1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2016;2(1):6-7.

DOI:

https://doi.org/10.15420/cfr.2015.2.1.6
The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelines

Ivan Milinkovic, Giuseppe Rosano, Yury Lopatin, et al

Citation: Cardiac Failure Review, 2016;2(2):123–9

DOI:

https://doi.org/10.15420/cfr.2016:13:1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2016;2(2):78.

DOI:

https://doi.org/10.15420/cfr.2016:2:2:ED1
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2015:1(2):62-3.

DOI:

https://doi.org/10.15420/cfr.2015.1.2.62
Foreword

Andrew JS Coats, Giuseppe Rosano,

Citation: Cardiac Failure Review 2015:1(1):6-7.

DOI:

https://doi.org/10.15420/cfr.2015.01.01.6
Sodium–Glucose Co-transporter 2 Inhibitors in Heart Failure: Recent Data and Implications for Practice

Giuseppe Rosano, David Quek, Felipe Martínez, et al

Published:

Citation: Cardiac Failure Review 2020;6:e31.

DOI:

https://doi.org/10.15420/cfr.2020.23

Keywords

Hypertension, Exercise Physiology, Insulin Resistance, Exercise Testing, Atrial Fibrillation, Blood Pressure, Exercise Intervention, Cardiology, Interventional Cardiology, Diabetes Mellitus, Metabolic Syndrome, Vascular Diseases, Endothelial Dysfunction, Endothelial Function, Pharmaceutical Care, Regulatory Affairs, Exercise Therapy, Pharma Sciences